H. R. 1405, titled the "Enhancing Domestic Drug Manufacturing Competitiveness Act," directs the Comptroller General of the United States to conduct a study to identify the main regulatory barriers that hinder the expansion or establishment of new pharmaceutical manufacturing...
Simple Explanation
Imagine you have a puzzle that's really hard to put together because there are lots of confusing rules. H.R. 1405 is like a plan where grown-ups study these rules to see if they can find ways to make it less tricky for companies to build places that make medicine, so everyone can get the medicine they need more easily and quickly.